Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Short-term Investments (2018 - 2025)

AC Immune (ACIU) has disclosed Short-term Investments for 8 consecutive years, with $80.8 million as the latest value for Q4 2025.

  • Quarterly Short-term Investments fell 45.2% to $80.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $80.8 million through Dec 2025, down 45.2% year-over-year, with the annual reading at $80.8 million for FY2025, 45.2% down from the prior year.
  • Short-term Investments for Q4 2025 was $80.8 million at AC Immune, down from $147.5 million in the prior quarter.
  • The five-year high for Short-term Investments was $147.5 million in Q4 2024, with the low at $27.7 million in Q4 2023.
  • Average Short-term Investments over 5 years is $95.3 million, with a median of $94.5 million recorded in 2022.
  • The sharpest move saw Short-term Investments plummeted 70.7% in 2023, then soared 432.86% in 2024.
  • Over 5 years, Short-term Investments stood at $125.8 million in 2021, then decreased by 24.91% to $94.5 million in 2022, then tumbled by 70.7% to $27.7 million in 2023, then skyrocketed by 432.86% to $147.5 million in 2024, then tumbled by 45.2% to $80.8 million in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $80.8 million, $147.5 million, and $27.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.